Motley Fool

Most of the index’s highest-yielding stocks come with a big asterisk, but they’re still worth a look.

Two announcements are electrifying investors’ enthusiasm today.

Insurance tech stock Lemonade is more than 65% off its 52-week high. Is the juice worth the squeeze?

Ignore the meme stock craze and focus on owning outstanding businesses.

Each has its own reason for being in your portfolio.

While the labor shortage isn’t an ideal situation for the economy, it could be a catalyst for this company.

A dip in price could be a buy signal.

One is at the beginning of its story. The others may enter new growth chapters down the road.

Wood is one of Coinbase’s few supporters, but maybe that will change if the company diversifies its revenue with…

The first clinical trial results for a candidate for the treatment of alpha-1 antitrypsin deficiency look highly encouraging.